WC
EPIX

Wexford Capital’s ESSA Pharma EPIX Stock Holding History

Wexford Capital’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$300K Hold
10,500
– – 0.05% 142
2021
Q1 		$305K Buy
10,500
+7,550
+256% +$175K 0.05% 162
2020
Q4 		$35K Sell
2,950
-20,050
-87% -$141K 0.01% 287
2020
Q3 		$159K Buy
23,000
+19,700
+597% +$134K 0.04% 116
2020
Q2 		$20K Buy
+3,300
New +$15.6K 0.01% 172

Other funds holding EPIX

Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Wexford Capital's EPIX Position: Q2 2021 in Review

Wexford Capital held its ESSA Pharma (EPIX) position steady in Q2 2021 at 10,500 shares worth $300K. The position accounts for 0.05% of the portfolio, ranked #142.

Wexford Capital first reported a position in EPIX in Q2 2020 and has held it in 5 quarters since. The position peaked at $305K in Q1 2021. 80 funds tracked by Wall St. Rank hold EPIX as of Q2 2021.

  • Wexford Capital held 10,500 shares of ESSA Pharma worth $300K as of Q2 2021.
  • Wexford Capital left its ESSA Pharma share count unchanged in Q2 2021.
  • ESSA Pharma made up 0.05% of Wexford Capital's portfolio in Q2 2021, its #142 holding.
  • Wexford Capital first reported a position in ESSA Pharma in Q2 2020 and has held it in 5 quarters since.
  • Wexford Capital's ESSA Pharma position peaked at $305K in Q1 2021.
  • 80 funds tracked by Wall St. Rank held ESSA Pharma as of Q2 2021.

Based on Wexford Capital's 13F filing for Q2 2021, filed 16 Aug 2021.